fluanisone structure
|
Common Name | fluanisone | ||
|---|---|---|---|---|
| CAS Number | 1480-19-9 | Molecular Weight | 356.434 | |
| Density | 1.1±0.1 g/cm3 | Boiling Point | 511.8±50.0 °C at 760 mmHg | |
| Molecular Formula | C21H25FN2O2 | Melting Point | 67.5-68.5° | |
| MSDS | N/A | Flash Point | 263.3±30.1 °C | |
Use of fluanisoneFluanisone is a typical antipsychotic and sedative of the butyrophenone chemical class. It is used in the treatment of schizophrenia and mania. It is also a component (along with fentanyl) of the injectable veterinary formulation fentanyl/fluanisone (Hypnorm) where it is used for rodent analgesia during short surgical procedures. |
| Name | 1-(4-fluorophenyl)-4-[4-(2-methoxyphenyl)piperazin-1-yl]butan-1-one |
|---|---|
| Synonym | More Synonyms |
| Density | 1.1±0.1 g/cm3 |
|---|---|
| Boiling Point | 511.8±50.0 °C at 760 mmHg |
| Melting Point | 67.5-68.5° |
| Molecular Formula | C21H25FN2O2 |
| Molecular Weight | 356.434 |
| Flash Point | 263.3±30.1 °C |
| Exact Mass | 356.190002 |
| PSA | 32.78000 |
| LogP | 3.43 |
| Vapour Pressure | 0.0±1.3 mmHg at 25°C |
| Index of Refraction | 1.558 |
| Storage condition | -20°C |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| HS Code | 2933599090 |
|---|
|
~92%
fluanisone CAS#:1480-19-9 |
| Literature: Narsaiah, A. Venkat; Nagaiah; Devi, B. Karuna Journal of Heterocyclic Chemistry, 2012 , vol. 49, # 4 p. 829 - 832 |
|
~%
fluanisone CAS#:1480-19-9 |
| Literature: Journal of Heterocyclic Chemistry, , vol. 49, # 4 p. 829 - 832 |
|
~%
fluanisone CAS#:1480-19-9 |
| Literature: Journal of Heterocyclic Chemistry, , vol. 49, # 4 p. 829 - 832 |
|
~%
fluanisone CAS#:1480-19-9 |
| Literature: Journal of Heterocyclic Chemistry, , vol. 49, # 4 p. 829 - 832 |
|
~%
fluanisone CAS#:1480-19-9 |
| Literature: Journal of Heterocyclic Chemistry, , vol. 49, # 4 p. 829 - 832 |
|
~%
fluanisone CAS#:1480-19-9 |
| Literature: Journal of Heterocyclic Chemistry, , vol. 49, # 4 p. 829 - 832 |
| HS Code | 2933599090 |
|---|---|
| Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
| 1-Butanone, 1- (4-fluorophenyl)-4-[4-(2-methoxyphenyl)-1-piperazinyl]- |
| Butyrophenone, 4'-fluoro-4-[4- (o-methoxyphenyl)-1-piperazinyl]- |
| Anti-Pica |
| 1-(4-fluorophenyl)-4-[4-(2-methoxyphenyl)-piperazine-1-yl]butan-1-one |
| Haloanisone |
| N1-(2-Methoxy-phenyl)-N4-<3-(4-fluor-benzoyl)-propyl>-piperazin |
| 1-Butanone, 1-(4-fluorophenyl)-4-[4-(2-methoxyphenyl)-1-piperazinyl]- |
| 1-(4-fluoro-phenyl)-4-[4-(2-methoxy-phenyl)-piperazin-1-yl]-butan-1-one |
| MD 2028 |
| 4'-fluoro-4-[4-(o-methoxyphenyl)-1-piperazinyl]butyrophenone |
| Fluanisonum [INN-Latin] |
| 1-(4-Fluorophenyl)-4-[4-(2-methoxyphenyl)-1-piperazinyl]-1-butanone |
| Sedalande |
| Fluanison |
| Metorin |
| 4-[4-(o-Methoxyphenyl)-1-piperazinyl]-p-fluorobutyrophenone |
| 1-(4-Fluorophenyl)-4-[4-(2-methoxyphenyl)piperazin-1-yl]butan-1-one |
| fluanisone |
| Haloanison |